Your browser doesn't support javascript.
loading
Tuberculosis drug discovery: Progression and future interventions in the wake of emerging resistance.
Perveen, Summaya; Kumari, Diksha; Singh, Kuljit; Sharma, Rashmi.
Affiliation
  • Perveen S; Infectious Diseases Division, CSIR- Indian Institute of Integrative Medicine, Jammu, 180001, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
  • Kumari D; Infectious Diseases Division, CSIR- Indian Institute of Integrative Medicine, Jammu, 180001, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
  • Singh K; Infectious Diseases Division, CSIR- Indian Institute of Integrative Medicine, Jammu, 180001, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
  • Sharma R; Infectious Diseases Division, CSIR- Indian Institute of Integrative Medicine, Jammu, 180001, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India. Electronic address: rashmi.sharma.09@iiim.res.in.
Eur J Med Chem ; 229: 114066, 2022 Feb 05.
Article in En | MEDLINE | ID: mdl-34973508
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 / 3_ND Database: MEDLINE Main subject: Extensively Drug-Resistant Tuberculosis / Mycobacterium tuberculosis / Antitubercular Agents Limits: Humans Language: En Journal: Eur J Med Chem Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 / 3_ND Database: MEDLINE Main subject: Extensively Drug-Resistant Tuberculosis / Mycobacterium tuberculosis / Antitubercular Agents Limits: Humans Language: En Journal: Eur J Med Chem Year: 2022 Document type: Article